Agios Pharmaceuticals, Inc.
AGIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $76 | $88 | $139 | $203 |
| Short-Term Investments | $817 | $689 | $644 | $817 |
| Receivables | $4 | $3 | $2 | $4 |
| Inventory | $28 | $19 | $8 | $0 |
| Other Curr. Assets | $40 | $35 | $39 | $40 |
| Total Curr. Assets | $966 | $834 | $833 | $1,064 |
| Property Plant & Equip (Net) | $55 | $70 | $88 | $104 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $638 | $29 | $314 | $266 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $5 | $4 | $4 | $3 |
| Total NC Assets | $698 | $103 | $406 | $374 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,663 | $937 | $1,239 | $1,438 |
| Liabilities | – | – | – | – |
| Payables | $17 | $10 | $19 | $17 |
| Short-Term Debt | $17 | $15 | $14 | $11 |
| Tax Payable | $1 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $47 | $43 | $30 | $32 |
| Total Curr. Liab. | $81 | $68 | $63 | $60 |
| LT Debt | $40 | $57 | $72 | $86 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $1 | $3 | $0 |
| Total NC Liab. | $41 | $58 | $75 | $86 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $57 | $72 | $86 | $97 |
| Total Liabilities | $122 | $126 | $138 | $146 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$149 | -$823 | -$471 | -$239 |
| AOCI | -$2 | -$0 | -$13 | -$1 |
| Other Equity | $1,691 | $1,634 | $1,584 | $1,532 |
| Total Equity | $1,541 | $811 | $1,101 | $1,292 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,663 | $937 | $1,239 | $1,438 |
| Net Debt | -$19 | -$16 | -$54 | -$106 |